Laguna Hills Health And Rehabilitation Center
LAGUNA HILLS HEALTH AND REHABILITATION CENTER in LAGUNA HILLS, CA — inspection on May 26, 2026.
Found 3 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
mattress setting down to the 160 pounds indicator. On 5/22/26 at 1129 hours, a follow up interview
to identify if the resident was comfortable, LVN 2 stated ask the resident.
When asked if Resident 1
aware of the observation when the LAL setting was at 230 and 160 lbs. LVN 2 acknowledge the LAL mattress settings were inaccurate.
056110 05/26/2026
Laguna Hills Health and Rehabilitation Center 24452 Health Center Drive Laguna Hills, CA 92653
an interview was conducted with LVN 4.
When asked if he had worked with Resident 1, LVN 4 stated
bleeding.
When asked if they were only monitored for bleeding, LVN 4 stated that I know of.
When
to monitor on the residents who were on anticoagulant medications, LVN 4 stated he would have to check, and that he was aware they are at high risk for bleeding. On 5/21/26 at 1601 hours, an interview was conducted with the DSD.
The DSD stated her role as the DSD was to provide onboard training, staffing education, and help with staffing.
When asked if CNAs were educated on what it means to be on a blood thinning medication, the DSD stated they knew to report any changes of conditions.
The DSD verified there were no in-service training provided to the staff on how to care for the residents on anticoagulant medications. On 5/22/26 at 0913 hours, an observation was made of CNA 1 providing bladder and bowel care and changing the residents gown. CNA 1 called for LVN 3 to join to assess Resident 1's skin. Resident 1 was observed to have bruising on her left and right arm, and discoloration under her left breast. On 5/26/26 at 1121 hours, an interview was conducted with the DON.
The DON was made aware about the staff interviews and acknowledged the findings.
Cross reference to F-F757.
056110 05/26/2026
Laguna Hills Health and Rehabilitation Center 24452 Health Center Drive Laguna Hills, CA 92653
Review of Resident 1's Order Summary Report showed a discontinued physician's order dated 4/29/26, to monitor for ecchymosis (bruising, abnormal bleeding, bloody stool, coffee ground emesis, vomitus, nosebleed, and skin tears.
Report to physician promptly (anticoagulant use) every shift.
Further review of the physician's order failed to show the monitoring for anticoagulant use was not ordered when Resident 1 was readmitted to the facility on [DATE].
Review of Resident 1's Admission/readmission Data Tool dated 5/13/26, showed healing Stage 3 on the coccyx, bruise on back to abdomen, and a dressing on upper back.Review of Resident 1's Order Summary Report dated 5/13/26, showed Pradaxa (blood thinner medication used to prevent and treat blood clots) oral capsule 110 mg (milligrams), give one capsule by mouth every 12 hours for atrial fibrillation (an irregular and often very rapid heart rhythm).
Review of Resident 1's MAR (Medication Administration Summary) for dated May 2026 showed Resident 1 was administered Pradaxa medication on the following dated and times:- dated 5/14/26 at 1700 hours;- dated 5/15/26 at 1700 hours;- dated 5/16/26 at 0900 hours;- dated 5/17/26 at 0900 hours, and 2100 hours;- dated 5/18/26 at 0900 hours, and 2100 hours;- dated 5/19/26 at 0900 hours, and 2100 hours;- dated 5/20/26 at 0900 hours, and 2100 hours;- dated 5/21/26 at 0900 hours, and 2100 hours; and- dated 5/22/26 at 0900 hours. On 5/22/26 at 0913 hours, an observation was conducted for Resident 1. Resident 1 was observed lying in bed with bruising on her left upper arm. On 5/22/26 at 1129 hours, an interview and concurrent medical record review was conducted with LVN 2.
When asked if Resident 1 was taking any anticoagulant medications, LVN 2 stated, yes Pradaxa.
When asked what were the side effects of taking an anticoagulant medication, LVN 2 stated skin discoloration, bleeding, ecchymosis and bleeding gums. LVN 2 verified Resident 1 was not monitored for side effects while taking an anticoagulant medication. On 5/26/26 at 1121 hours, an interview and concurrent medical record review for Resident 1 was conducted with the DON.
The DON verified Resident 1 had scattered discoloration to upper and lower extremities, and skin discoloration to the abdomen.
When asked what would be the process for the residents that were taking anticoagulants, the DON stated to monitor for bruising, bleeding, and discoloration.
The DON verified Resident 1 was not monitored for anticoagulant side effects.
Cross reference F-F726.
Frequently Asked Questions
More Reports
Source: This inspection report was downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases nursing home inspection reports in bulk. The findings reflect what state surveyors documented in the official Form CMS-2567 Statement of Deficiencies on the date of the inspection.
Plan of correction not included: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to their state survey agency and those responses may not appear in CMS public data at the time of release. The absence of a plan of correction in this report does not mean one was not filed. Readers who want information about corrective steps taken by the facility are encouraged to contact the facility or their state survey agency directly.
Corrections may have been made: This report reflects conditions observed on the date of the survey. The facility may have implemented staffing changes, additional training, policy revisions, or other corrective actions since this report was issued. We publish what CMS provides and encourage readers to seek current information from the facility.